BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 1466491)

  • 1. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease.
    Ahmad J; Sharma JM
    Am J Vet Res; 1992 Nov; 53(11):1999-2004. PubMed ID: 1466491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against hemorrhagic enteritis and Newcastle disease in turkeys by embryo vaccination with monovalent and bivalent vaccines.
    Ahmad J; Sharma JM
    Avian Dis; 1993; 37(2):485-91. PubMed ID: 8395802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
    Kapczynski DR; Martin A; Haddad EE; King DJ
    Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
    Stone H; Mitchell B; Brugh M
    Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of lentogenic Newcastle disease virus strain B-1 by cold adaptation.
    Gelb J; King DJ; Wisner WA; Ruggeri PA
    Avian Dis; 1996; 40(3):605-12. PubMed ID: 8883791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
    Miller PJ; King DJ; Afonso CL; Suarez DL
    Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease.
    Ge J; Wang X; Tian M; Wen Z; Feng Q; Qi X; Gao H; Wang X; Bu Z
    Vaccine; 2014 Mar; 32(13):1514-21. PubMed ID: 24486349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and immunogenicity of an in ovo vaccine against Newcastle disease virus differ between two lines of chicken.
    Dilaveris D; Chen C; Kaiser P; Russell PH
    Vaccine; 2007 May; 25(19):3792-9. PubMed ID: 17321645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of attenuated Salmonella typhimurium harbouring DNA vaccine against Newcastle disease virus].
    Pan ZM; Jiao XA; Huang JL; Yin YL; Tang LH; Zhang H; Zhang XM; Zhang XR; Liu XF
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):937-41. PubMed ID: 16496707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
    Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
    Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.
    Wen G; Li L; Yu Q; Wang H; Luo Q; Zhang T; Zhang R; Zhang W; Shao H
    PLoS One; 2017; 12(2):e0172812. PubMed ID: 28234989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.